Jasurolignoside from Ilex pubescens exerts a therapeutic effect on acute lung injury in vitro and in vivo by binding to TLR4

Abstract

Acute lung injury (ALI) is a severe disease caused by viral infection that triggers an uncontrolled inflammatory response. This study investigated the capacity of jasurolignoside (JO), a natural compound, to bind to Toll-like receptor 4 (TLR4) and treat ALI. The anti-inflammatory properties of JO were evaluated in vitro through Western blotting, enzyme-linked immunosorbent assay (ELISA), immunofluorescence staining, and co-immunoprecipitation. The investigation utilized a lipopolysaccharide (LPS)-induced ALI animal model to examine the therapeutic efficacy and mechanism of JO in vivo. JO attenuated inflammatory symptoms in infected cells and tissues by modulating the NOD-like receptor family pyrin domain containing protein 3 (NLRP3) inflammasome and the nuclear factor κB (NF-κB)/mitogen-activated protein kinase (MAPK) pathway. Molecular docking simulations revealed JO binding to TLR4 active sites, confirmed by cellular thermal shift assay. Surface plasmon resonance (SPR) demonstrated direct interaction between JO and TLR4 with a Kd value of 35.1 μmol·L^-1. Moreover, JO inhibited tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and IL-6 secretion and reduced leukocyte, neutrophil, lymphocyte, and macrophage infiltration in ALI-affected mice. JO also enhanced lung function and reduced ALI-related mortality. Immunohistochemical staining demonstrated JO’s ability to suppress TLR4 expression in ALI-affected mouse lung tissue. This study establishes that JO can bind to TLR4 and effectively treat ALI, indicating its potential as a therapeutic agent for clinical applications.

Keywords

Acute lung injury / Jasurolignoside / TLR4 / NF-κB/MAPKs / NLRP3

References

[1] Zhang J, Guo Y, Mak M, et al. Translational medicine for acute lung injury. J Transl Med. 2024;22:25. https://doi.org/10.1186/s12967-023-04828-7.

[2] D’Alessio FR. Mouse models of acute lung injury and ARDS. Methods Mol Biol. 2018; 1809:341-350. https://doi.org/10.1007/978-1-4939-8570-8_22.

[3] Gao H, Kang N, Hu C, et al. Ginsenoside Rb1 exerts anti-inflammatory effects in vitro and in vivo by modulating toll-like receptor 4 dimerization and NF-κB/MAPKs signaling pathways. Phytomedicine. 2020;69:153197. https://doi.org/10.1016/j.phymed.2020.153197.

[4] Yuan R, Huang L, Du LJ, et al. Dihydrotanshinone exhibits an anti-inflammatory effect in vitro and in vivo through blocking TLR4 dimerization. Pharmacol Res. 2019; 142:102-114. https://doi.org/10.1016/j.phrs.2019.02.01.

[5] Gao H, Cui Y, Kang N, et al. Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti‐inflammatory effects through blocking toll‐like receptor 4 dimerization. Br J Pharmacol. 2017; 174:2880-2896. https://doi.org/10.1111/bph.13912.

[6] Wang F, Fu X, Wu X, et al. Bone marrow derived M2 macrophages protected against lipopolysaccharide-induced acute lung injury through inhibiting oxidative stress and inflammation by modulating neutrophils and T lymphocytes responses. Int Immunopharmacol. 2018; 61:162-168. https://doi.org/10.1016/j.intimp.2018.05.015.

[7] Han S, Li S, Li J, et al. Hederasaponin C inhibits LPS‐induced acute kidney injury in mice by targeting TLR4 and regulating the PIP2/NF‐κB/NLRP3 signaling pathway. Phytother Res. 2023; 37:5974-5990. https://doi.org/10.1002/ptr.8014.

[8] He J, Yuan R, Cui X, et al. Anemoside B4 protects against Klebsiella pneumoniae-and influenza virus FM1-induced pneumonia via the TLR4/Myd88 signaling pathway in mice. Chin Med. 2020; 15:1-13. https://doi.org/10.1186/s13020-020-00350-w.

[9] Liu Z, Zhao H, Liu W, et al. NLRP3 inflammasome activation is essential for paraquat-induced acute lung injury. Inflammation. 2015; 38:433-444, https://doi.org/10.1007/s10753-014-0048-2.

[10] Saghahazrati S, Ayatollahi SA, Kobarfard F, et al. Attenuation of inflammation in streptozotocin-induced diabetic rabbits by Matricaria chamomilla oil: a focus on targeting NF-κB and NLRP3 signaling pathways. Chin Herb Med. 2020; 12:73-78, https://doi.org/10.1016/j.chmed.2019.12.003.

[11] Cai W, Chen J. Herbs used in traditional Chinese medicine in treatment of heart diseases. In: Bioactive Food as Dietary Interventions for Cardiovascular Disease. Academic Press: Cambridge, MA, USA, 2013:551-590.

[12] Hou XY, Liu YC, Du HZ. Potential role of Natural Herbal Tea as a healthy beverage in reducing the risk of liver cancer and chronic liver disease mortality. Chin J Nat Med. 2023; 21(12): 884-885, https://doi.org/10.1016/S1875-5364(23)60507-2.

[13] Jiang S, Cui H, Wu P, et al. Botany, traditional uses, phytochemistry, pharmacology and toxicology of Ilex pubescens Hook et Arn. J Ethnopharmacol. 2019;245:112147, https://doi.org/10.1016/j.jep.2019.112147.

[14] Shen YC, Hsieh PW, Kuo YH.Neolignan glucosides from Jasminum urophyllum. Phytochemistry. 1998; 48:719-723. https://doi.org/10.1016/j.jep.2017.02.013.

[15] Huang YL, Oppong MB, Guo Y, et al. The Oleaceae family: a source of secoiridoids with multiple biological activities. Fitoterapia. 2019;136:104155, https://doi.org/10.1016/j.fitote.2019.04.010.

[16] Han YH, Liu XD, Jin MH. et al. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases. Inflamm Res. 2023; 72:1839-1859, https://doi.org/10.1007/s00011-023-01790-4.

[17] Yuan R, Li Y, Han S. et al. Fe-curcumin nanozyme-mediated reactive oxygen species scavenging and anti-inflammation for acute lung injury. ACS Cent Sci. 2021; 8:10-21, https://doi.org/10.1021/acscentsci.1c00866.

[18] Zhang X, Lian X, Li H, et al. Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis. Chin Herb Med. 2022; 14:554-562, https://doi.org/10.1016/j.chmed.2021.03.002.

[19] Yi G, Li H, Liu M. et al.Soybean protein‐derived peptides inhibit inflammation in LPS‐induced RAW264. 7 macrophages via the suppression of TLR4‐mediated MAPK‐JNK and NF‐kappa B activation. J Food Biochem. 2020;44:e13289, https://doi.org/10.1111/jfbc.13289.

[20] Ikenohuchi YJ, Silva MDS, Rego CMA, et al. A C-type lectin induces NLRP3 inflammasome activation via TLR4 interaction in human peripheral blood mononuclear cells. Cell Mol Life Sci. 2023;80:188, https://doi.org/10.1007/s00018-023-04839-z.

[21] Li ST, Jiang Y, Wang J, et al. HO-1/autophagic flux axis alleviated sepsis-induced acute lung injury via inhibiting NLRP3 inflammasome. Cell Signal. 2022;100:110473. https://doi.org/10.1016/j.cellsig.2022.110473.

[22] Alluri R, Kutscher HL, Mullan BA, et al. Open tracheostomy gastric acid aspiration murine model of acute lung injury results in maximal acute nonlethal lung injury. J Vis Exp. 2017;120:e54700, https://doi.org/10.3791/54700.

[23] Yuan R, He J, Huang L, et al. Anemoside B 4 protects against acute lung injury by attenuating inflammation through blocking NLRP3 inflammasome activation and TLR4 dimerization. J Immunol Res. 2020: 2020:7502301. https://doi.org/10.1155/2020/7502301.

[24] Li XX, Yuan R, Wang QQ, et al. Rotundic acid reduces LPS‐induced acute lung injury in vitro and in vivo through regulating TLR4 dimer. Phytother Res. 2021; 35(8):4485-4498. https://doi.org/10.1002/ptr.7152.

[25] Bai B, Yang Y, Wang Q, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020: 11:1-18. https://doi.org/10.1038/s41419-020-02985-x.

[26] Ma Y, Wang Z, Wu X. et al. 5-Methoxytryptophan ameliorates endotoxin-induced acute lung injury in vivo and in vitro by inhibiting NLRP3 inflammasome-mediated pyroptosis through the Nrf2/HO-1 signaling pathway. Inflammation Res. 2023; 72:1633-1647, https://doi.org/10.1007/s00011-023-01769-1.

[27] Ryu JK, Kim SJ, Rah SH, et al. Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer. Immunity. 2017; 46:38-50. https://doi.org/10.1016/j.immuni.2016.11.007.

[28] Li L, Chen H, Huang G, et al. Structure of polysaccharide from Dendrobium nobile Lindl. and its mode of action on TLR4 to exert immunomodulatory effects. Foods. 2024;13:1356, https://doi.org/10.3390/foods13091356.

[29] Kochumon S, Wilson A, Chandy B, et al. Palmitate activates CCL4 expression in human monocytic cells via TLR4/MyD88 dependent activation of NF-κB/MAPK/PI3K signaling systems. Cell Physiol Biochem. 2018; 46:953-964, https://doi.org/10.1159/000488824.

[30] Wen Z, Liu W, Li X, et al. A protective role of the NRF2-Keap1 pathway in maintaining intestinal barrier function. Oxid Med Cell Longev. 2019;2019:1759149. https://doi.org/10.1155/2019/1759149.

[31] Yang CS, Shin DM, Jo EK. The role of NLR-related protein 3 inflammasome in host defense and inflammatory diseases. Int Neurourol J. 2012;16:2. https://doi.org/10.5213/inj.2012.16.1.2.

[32] Jhang JJ, Yen GC. The role of Nrf2 in NLRP3 inflammasome activation. Cell Mol Immunol. 2017; 14:1011-1012. https://doi.org/10.1038/cmi.2017.114.

[33] Yazal T, Lee PY, Chen PR, et al. Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis. Biomed Pharmacother. 2023;167:115619. https://doi.org/10.1016/j.biopha.2023.115619.

[34] Gao Y, Guo X, Zhou Y, et al. Kynurenic acid inhibits macrophage pyroptosis by suppressing ROS production via activation of the NRF2 pathway. Mol Med Rep. 2023; 28:1-11. https://doi.org/10.3892/mmr.2023.13098.

[35] Han S, Yuan R, Cui Y, et al. Hederasaponin C alleviates lipopolysaccharide-induced acute lung injury in vivo and in vitro through the PIP2/NF-κB/NLRP3 signaling pathway. Front Immunol. 2022;13:846384. https://doi.org/10.3389/fimmu.2022.846384.